Author:
Roy Shuvam,Kaul Anupma,Yachha Monika,Prasad Pallavi,Kushwaha Ravi S,Patel Manas,Prasad Narayan,Jain Manoj,Behera Manas Ranjan
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India;Kulkarni PS;EClinicalMedicine,2021
2. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial;Ella R;Lancet Infect Dis,2021
3. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction;Segal Y;Cell Mol Immunol,2018
4. New-onset autoimmune phenomena post-COVID-19 vaccination;Chen Y;Immunology,2022
5. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases;Kidney Int,2021